2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 30005093 | Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy. | 2018 Jul 1 | 1 |
| 2 | 30124725 | Rapid Onset of Action in Patients With Moderate-to-Severe Plaque Psoriasis With Halobetasol 0.01%/Tazarotene 0.045% Fixed Combination. | 2018 Aug 1 | 1 |